IndraLab
Statements
reach
"A significantly bigger clinical problem is loss-of-function mutations in KCNE1 and KCNQ1 leading to Long QT Syndrome [64], and hence it will be interesting in future research to examine whether SSD609 can be engineered to agonize rather than inhibit KCNQ1, although in this case, on-target toxicity might be difficult to avoid.3.2."